Panion & Bf Biotech Inc. (TPE:1760)
Taiwan · Delayed Price · Currency is TWD 54.60
+0.70 (1.30%)
Sep 30, 2026, 1:30 PM CST
Panion & Bf Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,621 | 5,402 | 7,039 | 9,603 | 15,347 | 6,448 | |
Market Cap Growth | -22.33% | -23.26% | -26.70% | -37.43% | 138.03% | -1.27% |
Enterprise Value | 4,782 | 5,666 | 7,320 | 9,937 | 15,340 | 6,616 |
Last Close Price | 53.90 | 60.95 | 77.60 | 104.25 | 164.09 | 67.99 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 21.56 | 28.40 | 56.53 | 124.36 | 84.17 | 61.76 |
Forward PE | - | 39.09 | 49.61 | 25.62 | 16.13 | 16.13 |
PS Ratio | 2.19 | 2.62 | 3.47 | 5.10 | 6.40 | 3.39 |
PB Ratio | 2.47 | 2.76 | 3.66 | 5.03 | 7.65 | 3.34 |
P/TBV Ratio | 2.48 | 2.78 | 3.68 | 5.06 | 7.71 | 3.37 |
P/FCF Ratio | 23.53 | 33.50 | 42.53 | - | 52.70 | 27.89 |
P/OCF Ratio | 13.57 | 17.45 | 20.04 | 54.13 | 31.33 | 16.07 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.27 | 2.75 | 3.61 | 5.28 | 6.40 | 3.48 |
EV/EBITDA Ratio | 10.53 | 13.42 | 21.42 | 33.32 | 28.08 | 24.00 |
EV/EBIT Ratio | 15.05 | 18.40 | 35.59 | 63.36 | 37.06 | 40.01 |
EV/FCF Ratio | 24.35 | 35.14 | 44.23 | - | 52.67 | 28.61 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.34 | 0.34 | 0.38 | 0.40 | 0.25 | 0.27 |
Debt / EBITDA Ratio | 1.39 | 1.51 | 1.97 | 2.32 | 0.86 | 1.66 |
Debt / FCF Ratio | 3.22 | 4.17 | 4.41 | - | 1.71 | 2.22 |
Net Debt / Equity Ratio | 0.09 | 0.11 | 0.09 | 0.12 | 0.02 | 0.09 |
Net Debt / EBITDA Ratio | 0.37 | 0.50 | 0.50 | 0.75 | 0.06 | 0.60 |
Net Debt / FCF Ratio | 0.82 | 1.32 | 1.03 | -58.88 | 0.12 | 0.72 |
Asset Turnover | 0.66 | 0.64 | 0.63 | 0.60 | 0.79 | 0.63 |
Inventory Turnover | 1.78 | 1.73 | 1.80 | 1.68 | 2.01 | 1.82 |
Quick Ratio | 0.78 | 0.87 | 0.93 | 0.85 | 0.90 | 0.96 |
Current Ratio | 1.32 | 1.45 | 1.47 | 1.41 | 1.52 | 1.72 |
Return on Equity (ROE) | 11.63% | 9.81% | 6.50% | 3.94% | 9.26% | 6.58% |
Return on Assets (ROA) | 6.17% | 5.98% | 3.99% | 3.10% | 8.56% | 3.43% |
Return on Invested Capital (ROIC) | 10.48% | 9.35% | 5.57% | 3.44% | 10.94% | 4.45% |
Return on Capital Employed (ROCE) | 15.00% | 13.90% | 9.40% | 7.20% | 19.10% | 7.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.65% | 3.52% | 1.77% | 0.80% | 1.19% | 1.62% |
FCF Yield | 4.25% | 2.99% | 2.35% | -0.04% | 1.90% | 3.59% |
Dividend Yield | 3.66% | 3.28% | 2.32% | 1.44% | 1.22% | 2.21% |
Payout Ratio | 71.84% | 81.15% | 103.28% | 222.07% | 70.53% | 51.45% |
Buyback Yield / Dilution | -0.14% | -0.11% | -0.01% | 0.04% | -8.32% | -3.18% |
Total Shareholder Return | 3.58% | 3.17% | 2.31% | 1.48% | -7.10% | -0.98% |